Kunal Remedies Profile
Key Indicators
- Authorised Capital ₹ 7.25 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.75 Cr
as on 24-10-2024
- Company Age 10 Year, 3 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 33.51 Cr
as on 24-10-2024
- Satisfied Charges ₹ 14.80 Cr
as on 24-10-2024
- Revenue 10.08%
(FY 2023)
- Profit -20.95%
(FY 2023)
- Ebitda 3.80%
(FY 2023)
- Net Worth 7.17%
(FY 2023)
- Total Assets -7.88%
(FY 2023)
About Kunal Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.25 Cr and a paid-up capital of Rs 4.75 Cr.
The company currently has active open charges totaling ₹33.51 Cr. The company has closed loans amounting to ₹14.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Agarwal, Kunal Goel, and Robin Goel serve as directors at the Company.
- CIN/LLPIN
U24233UP2015PTC068136
- Company No.
068136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kunal Remedies Private Limited offer?
Kunal Remedies Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiparasitic Drug, Common Disease Medicines, IV Fluids, Cardiovascular Drugs & Medication, Kidney Drugs.
Who are the key members and board of directors at Kunal Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Agarwal  | Director | 09-Jan-2015 | Current |
| Kunal Goel | Director | 09-Jan-2015 | Current |
| Robin Goel | Director | 09-Jan-2015 | Current |
Financial Performance of Kunal Remedies.
Kunal Remedies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.08% increase. The company also saw a substantial fall in profitability, with a 20.95% decrease in profit. The company's net worth moved up by a moderate rise of 7.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kunal Remedies?
In 2023, Kunal Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
J J Motels & Hotels Private LimitedActive 13 years 7 monthsAshok Agarwal, Kunal Goel and 1 more are mutual person
- Kunal Infraproject Private LimitedActive 13 years 3 months
Ashok Agarwal, Kunal Goel and 1 more are mutual person
- Four Squire Infracity Private LimitedActive 13 years 2 months
Ashok Agarwal and Robin Goel are mutual person
- Azure Infracity Private LimitedActive 13 years 2 months
Ashok Agarwal and Robin Goel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Jul 2024 | ₹8.00 M | Open |
Hdfc Bank Limited Creation Date: 08 Dec 2023 | ₹0.70 M | Open |
Others Creation Date: 26 Feb 2021 | ₹14.66 Cr | Open |
How Many Employees Work at Kunal Remedies?
Kunal Remedies has a workforce of 78 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kunal Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kunal Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
